New mRNA vaccines and gene therapeutics have gained media attention as a result of the coronavirus pandemic. These pharmaceuticals, known as ATMPs (Advanced Therapy Medicinal Products), contain living cells or the nucleic acids DNA or RNA. Producing such ATMPs in high quality requires customized produc-tion facilities and an associated range of services. The Fraunhofer Institute for Production Technology IPT from Aachen and Harro Höfliger from Allmersbach im Tal are now entering into a cooperation to develop fully automated ATMP production systems: Together, the partners are developing an offer for consult-ing, analysis and product development through to the serial production of mar-ketable ATMP systems. The cooperation was launched with the signing of the cooperation agreement on November 14, 2023 in Aachen.